Kaposiform Hemangioendothelioma (KHE)

Kaposiform Hemangioendothelioma (KHE) is a rare, locally aggressive vascular tumor that primarily affects infants and young children. Unlike common hemangiomas, KHE is known for its association with Kasabach-Merritt phenomenon (KMP), a life-threatening condition characterized by thrombocytopenia and coagulopathy. Understanding KHE’s symptoms, diagnosis, and treatment options is crucial for early intervention and better outcomes. What Is

Kaposi’s Sarcoma Skin Lesion: Causes, Symptoms, and Treatment

Kaposi’s sarcoma (KS) is a rare type of cancer that forms in the lining of blood and lymphatic vessels. It manifests as skin lesions that may appear red, purple, or brown. The disease is closely linked to human herpesvirus 8 (HHV-8) and is more prevalent among individuals with weakened immune systems, such as those with

Kaposi’s sarcoma

Kaposi’s sarcoma (KS) is a multifocal angioproliferative malignancy originating from lymphatic endothelial cells, characterized by the formation of vascular tumors primarily affecting the skin, mucous membranes, and visceral organs. First described by Moritz Kaposi in 1872, this neoplasm has been categorized into four distinct clinical variants: classic, endemic, epidemic (AIDS-associated), and iatrogenic (transplant-related). ​ Etiology